Table 1 Demographic and clinical characteristics of study subjects
From: IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis
HIV-LTBI- | HIV-LTBI+ | HIV + LTBI- | HIV + LTBI+ | HIV + TB+ | |
|---|---|---|---|---|---|
Number of participants | 35 | 40 | 35 | 40 | 40 |
Mean age | 34.4 ± 6.9 | 31.7 ± 7.1 | 32.4 ± 8.3 | 33.1 ± 6.5 | 34.6 ± 6.2 |
Percentages of males and females | 51, 49 | 55,45 | 43, 57 | 56,44 | 61,39 |
BCG scar percentage | 90% | 85% | 70% | 68% | 73% |
History of TB infection | No | No | No | No | No |
Mean CD4 counts | 747 ± 356 | 869 ± 408.9 | 408 ± 307.1 | 525 ± 323.3 | 250 ± 259 |
Mean CD8 counts | 836 ± 420.3 | 728 ± 334.3 | 1187 ± 606.7 | 1227 ± 913.5 | 663 ± 501.6 |
Mean years of onset of HIV infection | NA | NA | 9 | 10 | NA |
ART treatment | NA | NA | No | No | No |